Skip to main content
Year archive

ANGLE PLC — 2021 filings

All 57 regulatory filings released by ANGLE PLC (AGL) in 2021, sourced directly from the official regulator.

57 Filings
2021 Period
2021 filings (57)
Filing Released Lang
Issue of Equity
Declaration of Voting Results & Voting Rights Announcements
2021-12-22 English
Issue of Equity
Share Issue/Capital Change
2021-12-01 English
Parsortix in RNA analysis of CTCs as tool in NSCLC
Regulatory Filings
2021-12-01 English
Issue of Equity
Share Issue/Capital Change
2021-11-26 English
Issue of Equity
Share Issue/Capital Change
2021-11-17 English
Issue of LTIP Options and Share Options
Director's Dealing
2021-11-15 English
Appointment of Chief Medical Officer
Board/Management Information
2021-11-15 English
Issue of Equity
Share Issue/Capital Change
2021-11-12 English
Participation at Jefferies healthcare conference
Regulatory Filings
2021-11-12 English
Parsortix system showcased at NCRI Festival
Regulatory Filings
2021-11-11 English
Issue of Equity
Share Issue/Capital Change
2021-11-10 English
Change of Adviser
Regulatory Filings
2021-11-02 English
Issue of Equity
Declaration of Voting Results & Voting Rights Announcements
2021-10-21 English
Issue of Equity
Declaration of Voting Results & Voting Rights Announcements
2021-10-15 English
Issue of Equity
Share Issue/Capital Change
2021-09-30 English
Interim Results
Interim / Quarterly Report H1 2021
2021-09-30 English
Parsortix demonstrates ability to isolate CTCs
Legal Proceedings Report
2021-09-27 English
Study shows use of Parsortix to assess PD-L1
Regulatory Filings
2021-09-22 English
Parsortix enables gene expression analysis in mPCa
Legal Proceedings Report
2021-09-20 English
Notice of Interim Results and Webcast
Report Publication Announcement
2021-09-07 English
Director/PDMR Shareholding
Share Issue/Capital Change
2021-08-24 English
Study highlights superior performance of Parsortix
Environmental & Social Information
2021-08-09 English
Issue of Equity
Declaration of Voting Results & Voting Rights Announcements
2021-08-06 English
Issue of Equity
Share Issue/Capital Change
2021-08-03 English
Contract secured for bespoke assay development
Regulatory Filings
2021-07-28 English
Harvesting CTCs from brain metastasis patients
Regulatory Filings
2021-07-09 English
Director/PDMR Shareholding
Director's Dealing
2021-07-07 English
Issue of Equity
Share Issue/Capital Change
2021-07-02 English
Result of AGM
AGM Information
2021-06-30 English
Result of Accelerated Bookbuild
Share Issue/Capital Change
2021-06-25 English
Accelerated bookbuild to raise up to £20m
Capital/Financing Update
2021-06-24 English
Annual General Meeting update
AGM Information
2021-06-18 English
ctDNA and CTCs have differences in EGFR mutations
Regulatory Filings
2021-06-18 English
Update on submission for FDA clearance
Legal Proceedings Report
2021-06-04 English
Potential to prevent breast cancer relapse
Earnings Release Q2 2021
2021-06-01 English
Parsortix demonstrates oesophageal cancer utility
Regulatory Filings
2021-05-20 English
Exercise of options and total voting rights
Share Issue/Capital Change
2021-05-19 English
Parsortix study uncovers targets in TNBC patients
Regulatory Filings
2021-05-11 English
Exercise of options and total voting rights
Share Issue/Capital Change
2021-04-30 English
Preliminary Results
Earnings Release FY 2020
2021-04-29 English
Ovarian cancer study patient enrolment completed
Legal Proceedings Report
2021-04-26 English
Second Price Monitoring Extn
Regulatory Filings
2021-04-19 English
Price Monitoring Extension
Regulatory Filings
2021-04-19 English
Second Price Monitoring Extn
Regulatory Filings
2021-04-19 English
Price Monitoring Extension
Regulatory Filings
2021-04-19 English
First large-scale pharma services contract secured
Earnings Release FY 2021
2021-04-16 English
Notice of Preliminary Results and Webcast
Report Publication Announcement
2021-04-15 English
ANGLE's Parsortix system showcased at AACR 2021
Regulatory Filings
2021-04-12 English
Global launch of clinical services laboratories
Earnings Release Q1 2021
2021-03-30 English
Update on submission for FDA clearance
Legal Proceedings Report
2021-03-04 English
Parsortix-harvested CTCs uncover novel biomarker
Earnings Release Q1 2021
2021-02-18 English
Parsortix: Dynamic assessment of patient response
Environmental & Social Information
2021-02-08 English
Parsortix demonstrates high capture rate of CTCs
Regulatory Filings
2021-01-29 English
Holding(s) in Company
Major Shareholding Notification
2021-01-26 English
Research confirms high performance of Parsortix
Regulatory Filings
2021-01-20 English
Change of Auditor
Regulatory Filings
2021-01-12 English
Issue of Equity
Regulatory Filings
2021-01-05 English